期刊文献+

新型功能甜味剂——纽甜 被引量:14

New functional sweetener—Neotame
在线阅读 下载PDF
导出
摘要 纽甜作为一种新型功能性食品甜味剂,在食品工业中有着广泛的应用。本文综述了纽甜的性质、合成方法、结晶特性及其安全性。重点叙述了纽甜的合成方法和不同结晶晶型对纽甜的稳定性和溶解性的影响。 Neotame ( NTM), a derivative of aspartame, is a new nonnutritive and high - potency sweetener. It has a clean sweet taste and a good flavour profile, thus, it has been broadly utilized in food industry. Its properities, synthesis methods and crystal properities are detailed in this paper. Its preparation and the effect of different crystal type on its stability and solubility are in focus.
作者 曹中
出处 《中国食品添加剂》 CAS 2006年第6期153-156,共4页 China Food Additives
关键词 纽甜 合成 结晶晶型 Neotame synthesis Crystal type
  • 相关文献

参考文献12

  • 1郑建仙.功能性食品甜味剂[M].北京:中国轻工业出版社,2001.65-78.
  • 2郑建仙.低能量食品[M].北京:中国轻工业出版社,1997.348-369.
  • 3林洪,林杰.新一代强力甜味剂——纽甜[J].精细与专用化学品,2005,13(15):15-17. 被引量:18
  • 4D.A.Mayhew,H.H.Butchko,J.A.Thomas,W.W.Stargel,C.P.Comer,葛可佑.纽甜:安全性和功能作用综述[J].中国食物与营养,2004,10(7):32-46. 被引量:13
  • 5Claude.Nofre,Jean-Marie.Tinti,Food Chemistry,Neotame:discovery,properties,utility.69:245~257,2000.
  • 6Claude.Nofre et al.Method of preparing a compound derived from aspartame,useful as a sweetening agent,United States Patent 5,105,508,1996.
  • 7Prakash.Method for preparing and purifying an N-alkylated aspartame derivative,United States Patent 5,728,862,1998.
  • 8Kawahara,et al.Method for preparing highly stable crystals of aspartame derivative.United States Patent 6,844,465,2005.
  • 9Kishishita,et al.Aspartame derivative crystal and process for producing the same.United States Patent 6,790,470,2004.
  • 10Prakash,et al.Chemoenzymatic synthesis of neotam.United States Patent 6,627,431,2003.

二级参考文献88

  • 1Blackburn GL, Kanders BS, Lavin PT, Keller S.D, Whatley J: The effect of aspartame as part of a multidisciplinary weight-control program on short- and long-term control of body weight. Am J Clin Nutr 65:409-418, 1997.
  • 2DuBois GE, Waiters DE, Schiffman SS, Warwick ZS, Booth B J, Pecore SD, Gibes K, Carr BT, Brands LM.: Concentration-response relationships of sweeteners In: Walters DE, Orthoefer FT, DuBois GE (eds).""Sweeteners Discovery, Molecular Design, and Chemorecept
  • 3Butchko HH, Kotsonis FN: Acceptable daily intake and estimation of consumption. In: Tschanz C,Butchko HH, Stargel WW, Kotsonis FN (eds): ""The Clinical Evaluation of a Food Additive: Assessment of Aspartame."" Boca Raton, FL: CRC Press, pp 43-53,996.
  • 4Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LMJ,Geha RS, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny E J, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA
  • 5Hawkins D, Kirkpatrick D, Aikens P, Saxton J: PCR 1028. NC-00723: Pharmacokinetics of Single Doses in the Rat After Oral and Intravenous Administration. Huntingdon Life Sciences Ltd., research report submitted to the Food and Drug Administration, FAP 8A45
  • 6Kirkpatrick D, Aikens P, Nicholson J, Saxton J, Harris K.. PCR 1029. 14C-NC-00723 Metabolism and Pharmacokinetics in the Dog. Huntingdon Life Sciences Ltd., research report submitted to the Food and Drug Administration, FAP 8A4580. 1997c
  • 7Hawkins D, Kirkpatrick D, Aikens P, Saxton J: PCR 0959. 14C-NC-00723: Tissue Distribution in the Rat. Huntingdon Life Sciences Ltd., research report submitted to the Food and Drug Administration, FAP 8A4580. 1995a.
  • 8Hawkins D, Kirkpatrick D, Aikens P, Beeby T: PCR 0958. 14C-NC-00723: Determination of the Distribution in Rats by Whole-Body Autoradiography.Huntingdon Life Sciences Ltd., research report submitted to the Food and Drug Administration, FAP 8A4580.1995b.
  • 9Hawkins D, Aikens P, Beeby T: PCR 1031.14C-NC-00723: Determination of the Distribution in Pregnant and Non-Pregnant Rats by Whole-Body Autoradiography. Huntingdon Life Sciences Ltd., research report submitted to the Food and Drug Administration, FAP 8A458
  • 10Turk M, David E, Bartekian V: PCR 1044.Measurement of Concentrations of NC-00723 and NC00751 in Plasma Samples from a 104 Week Carcinogenicity Study in Mice. Phoenix International Life Sciences Inc., addendum to research report PCR 1014 submitted to the F

共引文献29

同被引文献85

引证文献14

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部